Trial Profile
Effects of nonbenzodiazepine, melatonin receptor agonist, and Kampo medication on sleep disturbances in perimenopausal and postmenopausal women
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; TJ 54 (Primary) ; Zolpidem (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 04 Jul 2011 New trial record